Annals of Surgical Oncology

, Volume 26, Issue 1, pp 86–92 | Cite as

Comprehensive Lateral Neck Dissection in Papillary Thyroid Carcinoma may Reduce Lateral Neck Recurrence Rates

  • Veljko StrajinaEmail author
  • Benzon M. Dy
  • Travis J. McKenzie
  • Zahraa Al-Hilli
  • Mabel Ryder
  • David R. Farley
  • Geoffrey B. Thompson
  • Melanie L. Lyden
Endocrine Tumors



To Identify predictors of recurrent disease following lateral neck dissection (LND) for papillary thyroid carcinoma (PTC).


A retrospective review of patients who underwent first-time LND for PTC at our institution (2000–2015) was performed. Medical records were examined for biopsy or pathologically proven lateral neck recurrence. Differences between the groups with and without recurrence were compared. All LNDs were then classified in to two groups: “comprehensive” (CND), involving levels IIa-Vb at minimum, or “selective”, labelling less extensive dissection (SND).


Four hundred nine patients underwent 467 LNDs. Surveillance data were available for 317 patients who underwent 362 LNDs (mean age 45 ± 16; range 18–88). The median follow-up was 64 ± 48 months (range 3–197). Recurrence was detected in 71 lateral necks (20%). The total number of lymph nodes was greater in the group without recurrence compared to those with recurrence (23 vs. 19, p = 0.02). Among patient demographics, radioactive iodine treatment, primary tumor characteristics and characteristics of nodal metastases, only an older patient age (mean 50 vs. 43 years) was associated with lateral neck recurrence (p < .01). CND was performed in 102 lateral necks and SND in 143 necks. There were 12 recurrences recorded in the CND group (12%) vs. 31 in the SND group (22%, p = .04). The majority of recurrences (70%) involved levels included in the original dissection.


Younger patients, more extensive dissection and a higher total number of lymph nodes removed are associated with a lower incidence of lateral neck recurrence after LND for papillary thyroid carcinoma.


  1. 1.
    Stack BC Jr, Ferris RL, Goldenberg D, et al. American thyroid association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid 2012;22(5):501–8.CrossRefGoogle Scholar
  2. 2.
    Farrag T, Lin F, Brownlee N, Kim M, Sheth S, Tufano RP. Is routine dissection of level II-B and V-A necessary in patients with papillary thyroid cancer undergoing lateral neck dissection for FNA-confirmed metastases in other levels. World J Surg. 2009;33(8):1680–3.CrossRefGoogle Scholar
  3. 3.
    Javid M, Graham E, Malinowski J, et al. Dissection of levels II through V is required for optimal outcomes in patients with lateral neck lymph node metastasis from papillary thyroid carcinoma. J Am Coll Surg. 2016;222(6):1066–73.CrossRefGoogle Scholar
  4. 4.
    Kang BC, Roh JL, Lee JH, et al. Candidates for limited lateral neck dissection among patients with metastatic papillary thyroid carcinoma. World J Surg. 2014;38(4):863–71.CrossRefGoogle Scholar
  5. 5.
    Roh JL, Kim JM, Park CI. Lateral cervical lymph node metastases from papillary thyroid carcinoma: pattern of nodal metastases and optimal strategy for neck dissection. Ann Surg Oncol. 2008;15(4):1177–82.CrossRefGoogle Scholar
  6. 6.
    Zhang XJ, Liu D, Xu DB, Mu YQ, Chen WK. Should level V be included in lateral neck dissection in treating papillary thyroid carcinoma? World J Surg Oncol. 2013;11:304.CrossRefGoogle Scholar
  7. 7.
    Albuja-Cruz MB, Thorson CM, Allan BJ, Lew JI, Rodgers SE. Number of lymph nodes removed during modified radical neck dissection for papillary thyroid cancer does not influence lateral neck recurrence. Surgery 2012;152(6):1177–83.CrossRefGoogle Scholar
  8. 8.
    Caron NR, Tan YY, Ogilvie JB, et al. Selective modified radical neck dissection for papillary thyroid cancer-is level I, II and V dissection always necessary? World J Surg. 2006;30(5):833–40.CrossRefGoogle Scholar
  9. 9.
    Lee L, Steward DL. Sonographically-directed neck dissection for recurrent thyroid carcinoma. Laryngoscope 2008;118(6):991–4.CrossRefGoogle Scholar
  10. 10.
    Grant CS, Stulak JM, Thompson GB, Richards ML, Reading CC, Hay ID. Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999–2006. World J Surg. 2010;34(6):1239–46.CrossRefGoogle Scholar
  11. 11.
    Al-Hilli Z, Strajina V, McKenzie TJ, Thompson GB, Farley DR, Richards ML. The role of lateral neck ultrasound in detecting single or multiple lymph nodes in papillary thyroid cancer. Am J Surg. 2016;212(6):1147–53.CrossRefGoogle Scholar
  12. 12.
    McNamara WF, Wang LY, Palmer FL, et al. Pattern of neck recurrence after lateral neck dissection for cervical metastases in papillary thyroid cancer. Surgery 2016;159(6):1565–71.CrossRefGoogle Scholar
  13. 13.
    Xu JJ, Yu E, McMullen C, et al. Patterns of regional recurrence in papillary thyroid cancer patients with lateral neck metastases undergoing neck dissection. J Otolaryngol Head Neck Surg. 2017;46(1):43.CrossRefGoogle Scholar
  14. 14.
    Robbins KT, Shaha AR, Medina JE, et al. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg. 2008;134(5):536–8.CrossRefGoogle Scholar
  15. 15.
    Davidson HC, Park BJ, Johnson JT. Papillary thyroid cancer: controversies in the management of neck metastasis. Laryngoscope 2008;118(12):2161–5.CrossRefGoogle Scholar
  16. 16.
    Chereau N, Buffet C, Tresallet C, Tissier F, Leenhardt L, Menegaux F. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: predictive factors and operative management. Surgery 2016;159(3):755–62.CrossRefGoogle Scholar
  17. 17.
    Kim SJ, Park SY, Lee YJ, et al. Risk factors for recurrence after therapeutic lateral neck dissection for primary papillary thyroid cancer. Ann Surg Oncol. 2014;21(6):1884–90.CrossRefGoogle Scholar
  18. 18.
    Randolph GW, Duh QY, Heller KS, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 2012;22(11):1144–52.CrossRefGoogle Scholar
  19. 19.
    Leboulleux S, Rubino C, Baudin E, et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab. 2005;90(10):5723–9.CrossRefGoogle Scholar
  20. 20.
    van Wilgen CP, Dijkstra PU, van der Laan BF, Plukker JT, Roodenburg JL. Shoulder complaints after neck dissection; is the spinal accessory nerve involved? Br J Oral Maxillofac Surg. 2003;41(1):7–11.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  • Veljko Strajina
    • 1
    Email author
  • Benzon M. Dy
    • 1
  • Travis J. McKenzie
    • 1
  • Zahraa Al-Hilli
    • 1
  • Mabel Ryder
    • 2
  • David R. Farley
    • 1
  • Geoffrey B. Thompson
    • 1
  • Melanie L. Lyden
    • 1
  1. 1.Department of SurgeryMayo ClinicRochesterUSA
  2. 2.Division of Endocrinology, Metabolism, Nutrition and DiabetesMayo ClinicRochesterUSA

Personalised recommendations